BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 4404559)

  • 1. Significance of cell interactions in production of graft versus host splenomegaly.
    Barchilon J; Liebhaber SA; Gershon RK
    Yale J Biol Med; 1972 Oct; 45(5):519-29. PubMed ID: 4404559
    [No Abstract]   [Full Text] [Related]  

  • 2. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 3. The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity.
    Rouse BT; Wagner H
    J Immunol; 1972 Dec; 109(6):1282-9. PubMed ID: 4404454
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation and suppression of graft-versus-host reaction.
    Nouza K; Pichlílová
    Allerg Immunol (Leipz); 1973; 19(2-4):279-89. PubMed ID: 4156162
    [No Abstract]   [Full Text] [Related]  

  • 5. T cells and the immune response.
    Cantor H
    Prog Biophys Mol Biol; 1972; 25():73-82. PubMed ID: 4145303
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of marrow allograft rejection with radioactive strontium: evidence for marrow-dependent effector cells.
    Bennett M
    J Immunol; 1973 Feb; 110(2):510-6. PubMed ID: 4405320
    [No Abstract]   [Full Text] [Related]  

  • 7. Status of T- and B-cell cooperation in radiation chimeras: evidence for a suppressor effect.
    Gengozian N; Urso P
    Transplant Proc; 1976 Dec; 8(4):631-5. PubMed ID: 793116
    [No Abstract]   [Full Text] [Related]  

  • 8. Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigens.
    Mathé G; Kiger N; Florentin I; Garcia-Giralt E; Martyre MC; Halle-Pannenko O; Schwartzenberg L
    Transplant Proc; 1973 Mar; 5(1):933-9. PubMed ID: 4144474
    [No Abstract]   [Full Text] [Related]  

  • 9. The double barrier in bone marrow transplantation.
    van Bekkum DW
    Semin Hematol; 1974 Jul; 11(3):325-40. PubMed ID: 4151846
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune responses of rats deficient in thymus-derived lymphocytes to strong transplantation antigens (Ag-B). Graft-versus-host activity, allograft rejection, and the factor of immunization.
    Rolstad B; Ford WL
    Transplantation; 1974 Apr; 17(4):405-15. PubMed ID: 4150884
    [No Abstract]   [Full Text] [Related]  

  • 11. Soluble H-2 antigens: effect on graft-versus-host reaction and factors influencing its effect on host-versus-skin-graft reaction.
    Halle-Pannenko O; Martyre MC; Mathé G
    Transplant Proc; 1972 Dec; 4(4):517-21. PubMed ID: 4405145
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppression and malignant lymphomas in graft-versus-host reactions.
    Solnik C; Gleichmann H; Kavanah M; Schwartz RS
    Cancer Res; 1973 Sep; 33(9):2068-77. PubMed ID: 4146854
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of macrophages, thymus- and bone marrow-derived cells in the graft-versus-host reaction.
    Argyris B
    Transplantation; 1974 Apr; 17(4):387-91. PubMed ID: 4150882
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro sensitization to transplantation antigens. V. Suppression of T-cell and of B-cell function in vitro.
    Dyminski JW; Argyris BF
    Cell Immunol; 1972 Dec; 5(4):561-9. PubMed ID: 4565650
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone marrow transplantation in inbred strains of mice. I. The failure of development of normal T cell function following allogeneic transplantation.
    Trier L; Rubin B
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Oct; 82B(5):724-32. PubMed ID: 4139875
    [No Abstract]   [Full Text] [Related]  

  • 16. Graft-versus-host response, measured by splenomegaly assay, by populations of allosensitized mouse lymphocytes.
    Lilliehöök B; Blomgren H
    Cell Immunol; 1976 May; 23(2):203-10. PubMed ID: 6152
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The graft-versus-host reaction.
    Seemayer TA; Gartner JG; Lapp WS
    Hum Pathol; 1983 Jan; 14(1):3-5. PubMed ID: 6219931
    [No Abstract]   [Full Text] [Related]  

  • 19. Proliferation-based T-cell selection for immunotherapy and graft-versus-host-disease prophylaxis in the context of bone marrow transplantation.
    Pachnio A; Dietrich S; Klapper W; Humpe A; Schwake M; Sedlacek R; Gramatzki M; Beck C
    Bone Marrow Transplant; 2006 Jul; 38(2):157-67. PubMed ID: 16820783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
    Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
    Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.